Treace Medical Concepts, Inc. Other Noncash Income (Expense)
Treace Medical Concepts, Inc. (TMCI) reported Other Noncash Income (Expense) of -$1.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-07
- Treace Medical Concepts, Inc. other noncash income (expense) for the quarter ending 2026-06-30 was -$796.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for the quarter ending 2026-03-31 was -$587.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for the quarter ending 2025-12-31 was -$458.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was -$531.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for fiscal 2025 was -$1.21M.
- Treace Medical Concepts, Inc. other noncash income (expense) for fiscal 2024 was -$538.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for fiscal 2023 was -$205.00K.
- Treace Medical Concepts, Inc. other noncash income (expense) for fiscal 2022 was -$25.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$796.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.38M 10-Q · filed 2026-08-07 | -$1.84M derived: sum of 3 quarters · filed 2026-08-07 | -$2.37M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$587.00K 10-Q · filed 2026-05-08 | -$1.04M derived: sum of 2 quarters · filed 2026-05-08 | -$1.58M derived: sum of 3 quarters · filed 2026-05-08 | -$1.61M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$989.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.02M derived: sum of 3 quarters · filed 2026-08-07 | -$1.21M 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$563.00K derived: sum of 2 quarters · filed 2026-08-07 | -$750.00K 10-Q · filed 2025-11-06 | -$1.11M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$219.00K 10-Q · filed 2026-08-07 | -$577.00K derived: sum of 3 quarters · filed 2026-08-07 | -$598.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$187.00K 10-Q · filed 2026-05-08 | -$545.00K derived: sum of 2 quarters · filed 2026-05-08 | -$566.00K derived: sum of 3 quarters · filed 2026-05-08 | -$635.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$379.00K derived: sum of 2 quarters · filed 2026-02-27 | -$448.00K derived: sum of 3 quarters · filed 2026-02-27 | -$538.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$90.00K derived: sum of 2 quarters · filed 2025-11-06 | -$180.00K 10-Q · filed 2025-11-06 | -$221.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | -$69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$159.00K 10-Q · filed 2025-08-07 | -$200.00K derived: sum of 3 quarters · filed 2026-02-27 | -$359.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | -$90.00K 10-Q · filed 2025-05-08 | -$131.00K derived: sum of 2 quarters · filed 2026-02-27 | -$290.00K derived: sum of 3 quarters · filed 2026-02-27 | -$295.00K derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$200.00K derived: sum of 2 quarters · filed 2026-02-27 | -$205.00K derived: sum of 3 quarters · filed 2026-02-27 | -$205.00K 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$164.00K derived: sum of 2 quarters · filed 2024-11-05 | -$164.00K 10-Q · filed 2024-11-05 | -$164.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$5.00K 10-Q · filed 2024-08-06 | -$5.00K derived: sum of 3 quarters · filed 2025-02-27 | -$30.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | -$25.00K 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | -$25.00K derived: sum of 3 quarters · filed 2025-02-27 | -$25.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$25.00K derived: sum of 2 quarters · filed 2025-02-27 | -$25.00K derived: sum of 3 quarters · filed 2025-02-27 | -$25.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$25.00K derived: sum of 2 quarters · filed 2023-11-09 | -$25.00K 10-Q · filed 2023-11-09 | -$25.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | ||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |